Charles River Laboratories International Inc
Charles River Laboratories Intern.../ US1598641074 /
CRL
18/10/2024 22:10:00
|
Chg.
-0.01
|
Volume |
Bid02:00:00 |
Ask02:00:00 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
197.77USD
|
-0.01%
|
707,810 Turnover: 91.19 mill. |
193.42Bid Size: 100 |
202.19Ask Size: 100 |
10.21 bill.USD |
- |
21.33 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
9.27 USD |
-3.13% |
EPS Diluted: |
9.22 USD |
-2.74% |
Revenues per Share: |
80.42 USD |
3.12% |
Book Value per Share: |
70.15 USD |
19.98% |
Cash Flow per Share: |
13.32 USD |
9.59% |
Dividend per Share: |
- USD |
- |
Total |
in mill. |
|
Revenues: |
4,129.41 USD |
3.86% |
Net Income: |
474.62 USD |
-2.39% |
Operating Cash Flow: |
683.90 USD |
- |
Cash and Cash Equivalents: |
276.77 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
21.33 |
25.50 |
P/S Ratio: |
2.46 |
2.94 |
P/BV ratio: |
2.82 |
3.37 |
P/CF Ratio: |
14.85 |
17.75 |
PEG: |
-6.81 |
-8.14 |
Earnings Yield: |
4.69% |
3.92% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
10.21 bill. USD |
12.14 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
51.63 mill. |
|
Profitability
Gross Profit Margin: |
36.39% |
EBIT Margin: |
14.95% |
Net Profit Margin: |
11.49% |
Return on Equity: |
13.18% |
Return on Assets: |
5.79% |
Financial Strength
Liquidity I / Cash Ratio: |
0.26% |
Liquidity II / Quick Ratio: |
1.00% |
Liquidity III / Current Ratio: |
1.52% |
Debt / Equity Ratio: |
0.73% |
Dynam. Debt / Equity Ratio: |
671.55% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
30/12/2023 |
Accounting Standard: |
US GAAP |